Select Medical Holdings Co. (NYSE:SEM) Shares Bought by Financial Strategies Group Inc.

Financial Strategies Group Inc. increased its stake in Select Medical Holdings Co. (NYSE:SEM) by 22.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,709 shares of the health services provider’s stock after purchasing an additional 1,938 shares during the quarter. Financial Strategies Group Inc.’s holdings in Select Medical were worth $363,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in SEM. Hexagon Capital Partners LLC increased its holdings in Select Medical by 528.7% in the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after buying an additional 645 shares in the last quarter. Transcendent Capital Group LLC purchased a new position in Select Medical in the 2nd quarter valued at approximately $35,000. Canada Pension Plan Investment Board acquired a new position in Select Medical during the second quarter worth $39,000. DekaBank Deutsche Girozentrale acquired a new stake in Select Medical in the second quarter valued at $60,000. Finally, GAMMA Investing LLC increased its position in shares of Select Medical by 52.8% in the second quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider’s stock valued at $70,000 after buying an additional 685 shares in the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Performance

Select Medical stock opened at $38.57 on Friday. The stock has a fifty day moving average price of $34.41 and a 200 day moving average price of $34.27. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical Holdings Co. has a 52 week low of $21.56 and a 52 week high of $40.50. The firm has a market capitalization of $4.99 billion, a P/E ratio of 18.02, a PEG ratio of 1.99 and a beta of 1.42.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period in the prior year, the firm posted $0.46 EPS. The company’s revenue was up 5.7% on a year-over-year basis. Equities research analysts anticipate that Select Medical Holdings Co. will post 2.16 earnings per share for the current year.

Select Medical Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th will be paid a dividend of $0.125 per share. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.50 annualized dividend and a dividend yield of 1.30%. Select Medical’s dividend payout ratio is presently 23.36%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on SEM shares. Bank of America started coverage on shares of Select Medical in a research report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective on the stock. Royal Bank of Canada upped their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday. StockNews.com cut shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Tuesday. Finally, Benchmark reiterated a “buy” rating and set a $48.00 target price on shares of Select Medical in a report on Friday, November 1st. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, Select Medical currently has a consensus rating of “Moderate Buy” and a consensus price target of $40.75.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.